Among the pairs differentially expressed in human disease, ITGAV receptor appeared to have a prominent role in MS as both the receptor and some of its ligands were upregulated in disease (ADAM15-, CCN1-, VWF-, FGF2-ITGAV; Supplementary Fig. 12 and Supplementary Data 7). Here, ITGAV is linked to myeloid sarcoma.